KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Total Debt (2016 - 2026)

Medtronic's Total Debt history spans 13 years, with the latest figure at $28.1 billion for Q1 2026.

  • For Q1 2026, Total Debt rose 5.5% year-over-year to $28.1 billion; the TTM value through Jan 2026 reached $28.1 billion, up 5.5%, while the annual FY2025 figure was $28.5 billion, 13.95% up from the prior year.
  • Total Debt for Q1 2026 was $28.1 billion at Medtronic, down from $29.1 billion in the prior quarter.
  • Across five years, Total Debt topped out at $29.1 billion in Q4 2025 and bottomed at $23.2 billion in Q3 2022.
  • The 5-year median for Total Debt is $26.6 billion (2025), against an average of $26.4 billion.
  • The largest annual shift saw Total Debt fell 17.04% in 2022 before it increased 13.95% in 2025.
  • A 5-year view of Total Debt shows it stood at $26.6 billion in 2022, then decreased by 5.77% to $25.1 billion in 2023, then rose by 12.94% to $28.3 billion in 2024, then grew by 2.73% to $29.1 billion in 2025, then dropped by 3.54% to $28.1 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Total Debt are $28.1 billion (Q1 2026), $29.1 billion (Q4 2025), and $28.6 billion (Q3 2025).